Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective
Chronic myeloid leukemia (CML) is a chronic condition with excellent long-term survival under tyrosine kinase inhibitor (TKI) therapy. However, patient priorities regarding treatment goals and quality of life remain insufficiently understood. We conducted a nationwide online survey among German CML...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2026
|
| In: |
Leukemia
Year: 2026, Jahrgang: 40, Heft: 1, Pages: 29-36 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-025-02826-w |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-025-02826-w Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-025-02826-w 
|
| Verfasserangaben: | Philipp Ernst, Cera Lohse, Michael Lauseker, Jan Geißler, Philipp le Coutre, Tim H. Brümmendorf, Susanne Saußele, Andreas Burchert, Georg-Nikolaus Franke, Paul La Rosée, Annamaria Brioli, Thomas Schenk, Christian Fabisch, Thomas Ernst, Guido Mehlkop and Andreas Hochhaus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1951207955 | ||
| 003 | DE-627 | ||
| 005 | 20260209165428.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260205s2026 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-025-02826-w |2 doi | |
| 035 | |a (DE-627)1951207955 | ||
| 035 | |a (DE-599)KXP1951207955 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ernst, Philipp |d 1983- |e VerfasserIn |0 (DE-588)1172212929 |0 (DE-627)1040983677 |0 (DE-576)514420715 |4 aut | |
| 245 | 1 | 0 | |a Treatment expectations and goals among patients with chronic myeloid leukemia in Germany |b a patient-centered perspective |c Philipp Ernst, Cera Lohse, Michael Lauseker, Jan Geißler, Philipp le Coutre, Tim H. Brümmendorf, Susanne Saußele, Andreas Burchert, Georg-Nikolaus Franke, Paul La Rosée, Annamaria Brioli, Thomas Schenk, Christian Fabisch, Thomas Ernst, Guido Mehlkop and Andreas Hochhaus |
| 264 | 1 | |c 2026 | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 19. Dezember 2025 | ||
| 500 | |a Gesehen am 05.02.2026 | ||
| 520 | |a Chronic myeloid leukemia (CML) is a chronic condition with excellent long-term survival under tyrosine kinase inhibitor (TKI) therapy. However, patient priorities regarding treatment goals and quality of life remain insufficiently understood. We conducted a nationwide online survey among German CML patients in collaboration with the German CML Alliance and patient organizations to assess treatment goals at diagnosis, during therapy, and in the treatment-free remission phase. The questionnaire included validated measures of treatment satisfaction, fear of progression, and quality-of-life priorities, supplemented by newly developed items. Between November 2024 and February 2025, 582 patients (median age 56 years, 48.8% female) completed the survey. Overall TKI tolerability was rated positively (median 4/5), particularly in first-line therapy and among patients with shorter disease duration, whereas long-term survivors reported more daily-life limitations. Younger patients ( < 45 years) emphasized fertility, sexuality, and work-related concerns, while older patients prioritized tolerability, independence, and mental health. Treatment history shaped expectations: those with discontinuation experience were more willing to accept adverse effects for the prospect of remission. Overall, patient priorities diverged between achieving deep molecular response and maintaining optimal tolerability. Integrating patient-reported preferences into shared decision-making may enhance satisfaction, adherence, and long-term outcomes of patients with CML. | ||
| 650 | 4 | |a Chronic myeloid leukaemia | |
| 650 | 4 | |a Quality of life | |
| 700 | 1 | |a Lohse, Cera |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lauseker, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Geißler, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a le Coutre, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brümmendorf, Tim Henrik |d 1966- |e VerfasserIn |0 (DE-588)115060219 |0 (DE-627)47758148X |0 (DE-576)289817625 |4 aut | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 700 | 1 | |a Burchert, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Franke, Georg-Nikolaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a La Rosée, Paul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brioli, Annamaria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schenk, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fabisch, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ernst, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mehlkop, Guido |d 1972- |e VerfasserIn |0 (DE-588)173564488 |0 (DE-627)674599209 |0 (DE-576)185902111 |4 aut | |
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 40(2026), 1, Seite 29-36 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Treatment expectations and goals among patients with chronic myeloid leukemia in Germany a patient-centered perspective |
| 773 | 1 | 8 | |g volume:40 |g year:2026 |g number:1 |g pages:29-36 |g extent:8 |a Treatment expectations and goals among patients with chronic myeloid leukemia in Germany a patient-centered perspective |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-025-02826-w |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41375-025-02826-w |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260205 | ||
| 993 | |a Article | ||
| 994 | |a 2026 | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |d 60000 |e 60000PS115839860 |e 61200PS115839860 |e 60000PS115839860 |k 0/60000/ |k 1/60000/61200/ |k 0/60000/ |p 7 | ||
| 999 | |a KXP-PPN1951207955 |e 4877039686 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Philipp","role":"aut","family":"Ernst","display":"Ernst, Philipp"},{"role":"aut","given":"Cera","display":"Lohse, Cera","family":"Lohse"},{"family":"Lauseker","display":"Lauseker, Michael","role":"aut","given":"Michael"},{"role":"aut","given":"Jan","family":"Geißler","display":"Geißler, Jan"},{"display":"le Coutre, Philipp","family":"le Coutre","role":"aut","given":"Philipp"},{"display":"Brümmendorf, Tim Henrik","family":"Brümmendorf","given":"Tim Henrik","role":"aut"},{"given":"Susanne","role":"aut","display":"Saußele, Susanne","family":"Saußele"},{"role":"aut","given":"Andreas","family":"Burchert","display":"Burchert, Andreas"},{"family":"Franke","display":"Franke, Georg-Nikolaus","role":"aut","given":"Georg-Nikolaus"},{"display":"La Rosée, Paul","family":"La Rosée","role":"aut","given":"Paul"},{"family":"Brioli","display":"Brioli, Annamaria","role":"aut","given":"Annamaria"},{"family":"Schenk","display":"Schenk, Thomas","role":"aut","given":"Thomas"},{"display":"Fabisch, Christian","family":"Fabisch","given":"Christian","role":"aut"},{"given":"Thomas","role":"aut","display":"Ernst, Thomas","family":"Ernst"},{"display":"Mehlkop, Guido","family":"Mehlkop","role":"aut","given":"Guido"},{"family":"Hochhaus","display":"Hochhaus, Andreas","given":"Andreas","role":"aut"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online veröffentlicht: 19. Dezember 2025","Gesehen am 05.02.2026"],"origin":[{"dateIssuedDisp":"2026","dateIssuedKey":"2026"}],"title":[{"subtitle":"a patient-centered perspective","title_sort":"Treatment expectations and goals among patients with chronic myeloid leukemia in Germany","title":"Treatment expectations and goals among patients with chronic myeloid leukemia in Germany"}],"id":{"eki":["1951207955"],"doi":["10.1038/s41375-025-02826-w"]},"name":{"displayForm":["Philipp Ernst, Cera Lohse, Michael Lauseker, Jan Geißler, Philipp le Coutre, Tim H. Brümmendorf, Susanne Saußele, Andreas Burchert, Georg-Nikolaus Franke, Paul La Rosée, Annamaria Brioli, Thomas Schenk, Christian Fabisch, Thomas Ernst, Guido Mehlkop and Andreas Hochhaus"]},"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"relHost":[{"title":[{"title":"Leukemia","title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal"}],"note":["Gesehen am 15.03.04"],"origin":[{"dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"pubHistory":["Nachgewiesen 11.1997 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Treatment expectations and goals among patients with chronic myeloid leukemia in Germany a patient-centered perspectiveLeukemia","physDesc":[{"extent":"Online-Ressource"}],"recId":"32046699X","id":{"zdb":["2008023-2"],"issn":["1476-5551"],"eki":["32046699X"]},"language":["eng"],"part":{"text":"40(2026), 1, Seite 29-36","issue":"1","pages":"29-36","year":"2026","volume":"40","extent":"8"}}],"recId":"1951207955"} | ||
| SRT | |a ERNSTPHILITREATMENTE2026 | ||